Jena University Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2018

  1. Nivolumab plus Ipilimumab versus Sunitinib in advanced renal-cell carcinoma

    New England Journal of Medicine, Vol. 378, Núm. 14, pp. 1277-1290